What is the effect of accompanying ankylosing spondylitis in treatment of Multiple Sclerosis? Is there a resistance

dc.authorid0000-0002-4988-1270
dc.authorid0000-0002-5595-7251
dc.authorid0000-0001-8140-6333
dc.authorid0000-0001-7689-7131
dc.authorid0000-0001-8986-155X
dc.contributor.authorTezcan, Ezgi Akyıldız.
dc.contributor.authorEkmekçi, Hakan.
dc.contributor.authorÖzdemir, Gökhan.
dc.contributor.authorGümüş, Haluk.
dc.contributor.authorÖztürk, Şerefnur.
dc.date.accessioned2020-03-26T20:19:45Z
dc.date.available2020-03-26T20:19:45Z
dc.date.issued2019
dc.departmentSelçuk Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractMultiple sclerosis (MS) is an autoimmune central nervous system disease characterized by inflammation, demyelination, and axonal damage (1). Ankylosing spondylitis (AS) is a common inflammatory rheumatic disease affecting the axial skeleton, which can cause structural and functional disorders and decreased quality of life, and cause a characteristic back pain and position (2). The coexistence of MS and AS is rare. Besides the neurogenetic and neuroepidemiologic aspects of this association, there may be an interactive interaction in the treatment. It may be necessary to examine the effect of this situation on the roadmap to be followed in the treatment of both diseases.en_US
dc.identifier.citationTezcan, E. A., Ekmekçi, H., Özdemir, G., Gümüş, H., Öztürk, Ş. (2019). What is the Effect of Accompanying Ankylosing Spondylitis in Treatment of Multiple Sclerosis? Is there a Resistance?. Turkish Journal of Neurology, 25(3), 182-183.
dc.identifier.doi10.4274/tnd.galenos.2019.93206en_US
dc.identifier.endpage183en_US
dc.identifier.issn1301-062Xen_US
dc.identifier.issn1309-2545en_US
dc.identifier.issue3en_US
dc.identifier.pmid#YOKen_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage182en_US
dc.identifier.urihttps://dx.doi.org/10.4274/tnd.galenos.2019.93206
dc.identifier.urihttps://hdl.handle.net/20.500.12395/38389
dc.identifier.volume25en_US
dc.identifier.wosWOS:000487283000016en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorTezcan, Ezgi Akyıldız.
dc.institutionauthorEkmekçi, Hakan.
dc.institutionauthorÖzdemir, Gökhan.
dc.institutionauthorGümüş, Haluk.
dc.institutionauthorÖztürk, Şerefnur.
dc.language.isoenen_US
dc.publisherTURKISH NEUROLOGICAL SOCen_US
dc.relation.ispartofTURKISH JOURNAL OF NEUROLOGYen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectAnkylosing spondylitisen_US
dc.subjectmultiple sclerosisen_US
dc.subjectdemyelinationen_US
dc.titleWhat is the effect of accompanying ankylosing spondylitis in treatment of Multiple Sclerosis? Is there a resistanceen_US
dc.title.alternativeMultipl Sklerozda eşlik eden ankilozan spondilitin tedaviye etkisi ne düzeydedir? Bir direnç söz konusu olabilir mien_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Ezgi Akyıldız TEZCAN.pdf
Boyut:
164.74 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Full Text Access